NCT06537999 - A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2028

Conditions

Multifocal Motor Neuropathy

Interventions

DRUG

DNTH103

"* Day 1: IV loading dose~* Week 1 to Week 15: DNTH103 administered SC every 2 weeks"

DRUG

Placebo

"* Day 1: IV infusion of placebo~* Week 1 to Week 15: placebo administered SC every 2 weeks"

Trial Locations (26)

1105

RECRUITING

Clinical Study Site, Amsterdam

1172

RECRUITING

Clinical Study Site, Copenhagen

8200

RECRUITING

Clinical Study Site, Aarhus

11000

RECRUITING

Clinical Study Site, Belgrade

13005

RECRUITING

Clinical Study Site, Marseille

27599

RECRUITING

Clinical Study Site, Chapel Hill

33620

RECRUITING

Clinical Study Site, Tampa

34205

RECRUITING

Clinical Study Site, Bradenton

43210

RECRUITING

Clinical Study Site, Columbus

45219

RECRUITING

Clinical Study Site, Cincinnati

66103

RECRUITING

Clinical Study Site, Kansas City

77030

RECRUITING

Clinical Study Site, Houston

85251

RECRUITING

Clinical Study Site, Scottsdale

90048

RECRUITING

Clinical Study Site, Los Angeles

94000

RECRUITING

Clinical Study Site, Paris

96817

RECRUITING

Clinical Study Site, Honolulu

00189

RECRUITING

Clinical Study Site, Rome

Unknown

RECRUITING

Clinical Study Site, Utrecht

RECRUITING

Clinical Study Site, Skopje

RECRUITING

Clinical Study Site, London

RECRUITING

Clinical Study Site, Oxford

85-090

RECRUITING

Clinical Study Site, Bydgoszcz

40-689

RECRUITING

Clinical Study Site, Katowice

30-688

RECRUITING

Clinical Study Site, Krakow

31-202

RECRUITING

Clinical Study Site, Krakow

08035

RECRUITING

Clinical Study Site, Barcelona